Socialiya - Entertainment. Knowledge. Community.
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 yea...

HEALTH NEWS June 04, 2026

Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years.

9 views 0 likes 0 comments
Share:
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years.

Author: The Guardian

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya